1. Home
  2. PBYI vs UFG Comparison

PBYI vs UFG Comparison

Compare PBYI & UFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • UFG
  • Stock Information
  • Founded
  • PBYI 2010
  • UFG 2021
  • Country
  • PBYI United States
  • UFG Singapore
  • Employees
  • PBYI N/A
  • UFG N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • UFG Oil Refining/Marketing
  • Sector
  • PBYI Health Care
  • UFG Energy
  • Exchange
  • PBYI Nasdaq
  • UFG Nasdaq
  • Market Cap
  • PBYI 138.4M
  • UFG 149.8M
  • IPO Year
  • PBYI N/A
  • UFG 2025
  • Fundamental
  • Price
  • PBYI $3.07
  • UFG $4.85
  • Analyst Decision
  • PBYI Strong Buy
  • UFG
  • Analyst Count
  • PBYI 1
  • UFG 0
  • Target Price
  • PBYI $7.00
  • UFG N/A
  • AVG Volume (30 Days)
  • PBYI 275.3K
  • UFG 517.4K
  • Earning Date
  • PBYI 05-08-2025
  • UFG 01-01-0001
  • Dividend Yield
  • PBYI N/A
  • UFG N/A
  • EPS Growth
  • PBYI 37.78
  • UFG N/A
  • EPS
  • PBYI 0.62
  • UFG 0.01
  • Revenue
  • PBYI $230,468,000.00
  • UFG $155,193,013.00
  • Revenue This Year
  • PBYI N/A
  • UFG N/A
  • Revenue Next Year
  • PBYI N/A
  • UFG N/A
  • P/E Ratio
  • PBYI $4.92
  • UFG $889.73
  • Revenue Growth
  • PBYI N/A
  • UFG 119.24
  • 52 Week Low
  • PBYI $2.23
  • UFG $3.50
  • 52 Week High
  • PBYI $5.20
  • UFG $6.13
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 51.76
  • UFG N/A
  • Support Level
  • PBYI $2.88
  • UFG N/A
  • Resistance Level
  • PBYI $3.14
  • UFG N/A
  • Average True Range (ATR)
  • PBYI 0.14
  • UFG 0.00
  • MACD
  • PBYI 0.01
  • UFG 0.00
  • Stochastic Oscillator
  • PBYI 64.00
  • UFG 0.00

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About UFG Uni-Fuels Holdings Limited Class A Ordinary Shares

Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.

Share on Social Networks: